[go: up one dir, main page]

NO925048L - Arylalkylestere av 4,5-dihydroksy-9,10-dihydro-9,10-diokso-2-antracenkarboksylsyre med terapeutisk aktivitet - Google Patents

Arylalkylestere av 4,5-dihydroksy-9,10-dihydro-9,10-diokso-2-antracenkarboksylsyre med terapeutisk aktivitet

Info

Publication number
NO925048L
NO925048L NO92925048A NO925048A NO925048L NO 925048 L NO925048 L NO 925048L NO 92925048 A NO92925048 A NO 92925048A NO 925048 A NO925048 A NO 925048A NO 925048 L NO925048 L NO 925048L
Authority
NO
Norway
Prior art keywords
dioxo
dihydro
acid
antracencarboxylic
arylal
Prior art date
Application number
NO92925048A
Other languages
English (en)
Other versions
NO925048D0 (no
NO179245C (no
NO179245B (no
Inventor
Sergio Rosini
Maurizio Mian
Original Assignee
Gentili Ist Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gentili Ist Spa filed Critical Gentili Ist Spa
Publication of NO925048L publication Critical patent/NO925048L/no
Publication of NO925048D0 publication Critical patent/NO925048D0/no
Publication of NO179245B publication Critical patent/NO179245B/no
Publication of NO179245C publication Critical patent/NO179245C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/95—Esters of quinone carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/24—Anthracenes; Hydrogenated anthracenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
NO925048A 1991-05-03 1992-12-30 Arylalkylestere av 4,5-dihydroksy-9,10-dihydro-9,10-diokso-2-antracenkarboksylsyre med terapeutisk aktivitet NO179245C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI911215A IT1247884B (it) 1991-05-03 1991-05-03 Esteri arilalchilici dell'acido 4,5 diidrossi-9,10-diidro-9,10-diosso 2-antracencarbossilico ad azione terapeutica
PCT/EP1992/000881 WO1992019584A1 (en) 1991-05-03 1992-04-21 Arylalkyl esters of 4,5-dihydroxy-9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic acid having therapeutical activity

Publications (4)

Publication Number Publication Date
NO925048L true NO925048L (no) 1992-12-30
NO925048D0 NO925048D0 (no) 1992-12-30
NO179245B NO179245B (no) 1996-05-28
NO179245C NO179245C (no) 1996-09-04

Family

ID=11359835

Family Applications (1)

Application Number Title Priority Date Filing Date
NO925048A NO179245C (no) 1991-05-03 1992-12-30 Arylalkylestere av 4,5-dihydroksy-9,10-dihydro-9,10-diokso-2-antracenkarboksylsyre med terapeutisk aktivitet

Country Status (21)

Country Link
US (1) US5330981A (no)
EP (1) EP0537313B1 (no)
JP (1) JPH0692348B2 (no)
KR (1) KR100226082B1 (no)
AT (1) ATE133157T1 (no)
AU (1) AU648894B2 (no)
BR (1) BR9205255A (no)
CZ (1) CZ280027B6 (no)
DE (1) DE69207698T2 (no)
DK (1) DK0537313T3 (no)
ES (1) ES2082468T3 (no)
FI (1) FI104166B (no)
GR (1) GR3019417T3 (no)
HU (1) HUT63605A (no)
IT (1) IT1247884B (no)
MX (1) MX9202015A (no)
NO (1) NO179245C (no)
PT (1) PT100439B (no)
RU (1) RU2087462C1 (no)
SK (1) SK280738B6 (no)
WO (1) WO1992019584A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9417102D0 (en) * 1994-08-24 1994-10-12 Lilly Industries Ltd Pharmaceutical compounds
ES2254470T3 (es) * 2000-08-29 2006-06-16 Nobex Corporation Compuestos inmunorreguladores, derivados de los mismos y su uso.
US8048924B2 (en) 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
PL1773767T3 (pl) 2004-07-07 2016-07-29 Biocon Ltd Synteza azowo związanych związków immunoregulacyjnych
CN101475484B (zh) * 2009-01-05 2012-07-18 东南大学 骨靶向抗炎药物合成方法及其应用
CN103709052B (zh) * 2014-01-12 2016-01-27 何黎琴 一种大黄酸胺基醇酯类化合物、其制备方法及医药用途
CN104945269A (zh) * 2015-06-23 2015-09-30 常州善美药物研究开发中心有限公司 一种大黄酸羧酸酯类衍生物及其应用
CN109053798B (zh) * 2018-07-23 2020-11-17 遵义医科大学 一种大黄酸酯衍生物及其制备方法与应用
CN115521320B (zh) * 2021-06-25 2023-09-05 沈阳兴齐眼药股份有限公司 一种制备普拉洛芬的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA761627B (en) * 1976-03-16 1978-01-25 C Friedmann Improvements in or relating to the treatment of arthritis

Also Published As

Publication number Publication date
WO1992019584A1 (en) 1992-11-12
US5330981A (en) 1994-07-19
FI104166B1 (fi) 1999-11-30
AU648894B2 (en) 1994-05-05
PT100439B (pt) 1999-10-29
AU1670092A (en) 1992-12-21
FI925944A (fi) 1992-12-30
ATE133157T1 (de) 1996-02-15
CZ386492A3 (en) 1993-06-16
DE69207698D1 (de) 1996-02-29
FI104166B (fi) 1999-11-30
DE69207698T2 (de) 1996-07-18
SK386492A3 (en) 1995-04-12
HU9204171D0 (en) 1993-04-28
RU2087462C1 (ru) 1997-08-20
JPH05507733A (ja) 1993-11-04
EP0537313B1 (en) 1996-01-17
SK280738B6 (sk) 2000-07-11
DK0537313T3 (da) 1996-06-03
FI925944A0 (fi) 1992-12-30
ITMI911215A0 (it) 1991-05-03
BR9205255A (pt) 1993-08-31
NO925048D0 (no) 1992-12-30
JPH0692348B2 (ja) 1994-11-16
IT1247884B (it) 1995-01-05
NO179245C (no) 1996-09-04
CZ280027B6 (cs) 1995-09-13
ES2082468T3 (es) 1996-03-16
EP0537313A1 (en) 1993-04-21
PT100439A (pt) 1993-08-31
HUT63605A (en) 1993-09-28
NO179245B (no) 1996-05-28
ITMI911215A1 (it) 1992-11-03
KR100226082B1 (en) 1999-10-15
MX9202015A (es) 1992-11-01
GR3019417T3 (en) 1996-06-30

Similar Documents

Publication Publication Date Title
NO942468L (no) Fremgangsmåte for fremstilling av 2-alkyl-3,4,6-trifluorbenzoesyre
DE10199020I2 (de) Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
FR2617488B1 (fr) Procede de fabrication de structures organisees de collagene, notamment d'origine humaine, et structures organisees de collagene correspondantes
IT1217303B (it) Ceppi batterici particolarmente utili per la produzione di vaccini per il trattamenmto di malattie intestinali e simili e metodo di ingegneria gentica per la produzione dei detti vaccini
ES8800160A1 (es) Procedimiento de obtencion de acidos quinolincarboxilicos con propiedades antibacteriales.
ATE203907T1 (de) Dermatologische zubereitung zur behandlung von aktinischen keratosen
DE69130497D1 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
FR2656214B1 (fr) Cadre dynamique d'osteosynthese du rachis.
FR2491334B1 (no)
NO925048D0 (no) Arylalkylestere av 4,5-dihydroksy-9,10-dihydro-9,10-diokso-2-antracenkarboksylsyre med terapeutisk aktivitet
ATA900589A (de) Stereospezifisches verfahren fuer die herstellung von enantiomeren des 3-substituierten furo (3,4-c) pyridins, so erhaltene enantiomere oder mischungen davon sowie diese enthaltene therapeutische mittel
BE895961A (fr) Procede de preparation d'un clone bacterien produisant de 1'alpha 1-antitrypsine humaine
ATE89728T1 (de) Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen.
LV10839A (lv) Arstniecibas lidzeklis lipidu un holesterina vielmainas traucejumu profilaksei un arstesanai so traucejumu profilakses un arstesanas panemiens
TR27462A (tr) Sübstitüe edilmis sinamik asidi hidroksiamid'leri, bunlarin üretilmesine mahsus usul, bunlari ihtiva eden maddeler ve bunlarin kullanilmasi.
FR2605184B1 (fr) Nouveau micro-organisme et procede de culture l'utilisant
NO952904L (no) Lysinsalt av 6-klor-5-fluor-3-(2-tenoyl)-2-oxindol-1-karboksamide
DE68905479D1 (de) Transdermate magensafthemmende wirkstoffe zur behandlung von magen-darm-erkrankungen.
IT8019033A0 (it) Metodo per il trattamento disuperfici siero-essudanti dell'epidermide, ferite, piaghe esimili, e mezzi per la sua attuazione.
ATE101054T1 (de) Einrichtung zur diagnostik und behandlung von nasenerkrankungen.
DE68906028D1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
IT8324322A0 (it) Metodo e composizione per il trattamento topico di alcune patologiche cutanee.
ATE88090T1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN OCTOBER 2001